–
The Comptroller General’s Department added a list of drugs. For patients with chronic skin disease To cover more treatment Direct disbursement starts Jan. 15.
Mr. Poomsak Aranya Kasemsuk Director-General of the Comptroller General’s Department revealed that the Comptroller General’s Department of Dermatologists Association of Thailand Consider adding benefits for people with severe, moderate, and very severe psoriasis. And pemphigus patients Who are patients in chronic skin diseases To cover more necessary medical care
The Department therefore canceled the criteria and guidelines for disbursing medical benefits. For patients with severe, moderate, and very severe psoriasis. And set the criteria for medical expenses reimbursement For patients with chronic skin disease (Dermatology Disease Prior Authorization (DDPA)).
By entitled persons or family members Can use the right to reimburse medical benefits in the direct medical expense reimbursement system only. No advance payment required, effective from January 15, 2021 onwards with details as follows
1.List of Infliximab, Secukinumab and Etanercept for Psoriasis
2. List of drugs Rituximab for patients with Pemphigus
3. The treating doctor, if there is a plan to use the drug, please register the patient’s doctor. And send information according to the protocol specified in the DDPA system to request approval for the reimbursement of drugs Or request an extension of the reimbursement for medication Or ask to stop using drugs
4. For the same patient whose use of Etanercept or Infliximab was approved, the drug can be used until treatment is stopped.
“Due to the body of knowledge and medical technology continually advancing And there is a list of biological or synthetic drugs aimed at the effective treatment of patients with chronic skin diseases. Resulting in improved patient quality of life By the Comptroller General’s Department and the Association of Dermatologists of Thailand Will jointly determine the criteria for reimbursement of medical expenses for patients with chronic skin diseases on a continuous basis So that the treatment is reasonable Consistent with the evolution of medicine And will benefit the right person or family members in the future, “said the Director-General of the Comptroller General.
–
